Syneos Health Podcast | Biopharma and the Emergency Department
The emergency department (ER) can be a place of chaos, panic and infinite amounts of unpredictability. Not knowing what can come through the doors at any given time makes this environment impossible to foresee and prepare for. Because of this uncertainty, the ER (and its patients) can be a particularly challenging target for clinical trials.
Dr. Ruth Henrice-Desrosiers, Medical Director, Syneos Health joins the podcast to discuss critical aspects to be considered by biopharma companies when choosing to bring a clinical trial to the ER—from location and cost implications to informed consent challenges, and everything in between.
The views expressed in this podcast belong solely to the speakers and do not represent those of their organization.
Related
Looking for exclusive insight?
